Skip to main content
. 2022 Nov 20;11(4):72. doi: 10.3390/antib11040072

Table 3.

Cross-reactivity of TBEV with other members of the Flaviviridae family.

Country Flavivirus % Cross-Reactivity Method Reference
Germany DENV (1–4) IgG 25.9%—TBE
patients
IgG 9.5%—vaccinated
individuals
ELISA
Allwinn et al. (2002) [27]
United Kingdom LIV 68% Mansfield et al. (2011) [20]
DENV-2 38.5% VNT
WNV 7.1%—vaccinated against TBEV and JEV,
32.1%—vaccinated against TBEV, JEV, and YFV
Austria OHFV 98–100% VNT Orlinger et al. (2011) [29]
Japan OHFV 79–86% VNT Chidumayo et al. (2014) [22]
Germany LIV 80% 1 ELISA/VNT Klaus et al. (2014) [3]
WNV 26% 1
Croatia WNV
USUV
IgG 15.4%; IgM 8.0%
IgG 13.5%
ELISA Project CRONEUROARBO
(2017–2021), unpublished data
United States of America,
United Kingdom, Czech Republic
LGTV, LIV, OHFV, POWV, KFDV Neutralizing activity
detected
VNT Agudelo et al. (2021) [19]

1 Animal samples (sheep, horses, respectively). ELISA = enzyme-linked immunosorbent assay; VNT = virus neutralization test; DENV = dengue virus, LIV = louping ill virus, WNV = West Nile virus, TBEV = tick-borne encephalitis virus; JEV = Japanese encephalitis virus; OHFV = Omsk hemorrhagic fever, USUV = Usutu virus; LGTV = Langat virus, POWV = Powassan virus, KFDV = Kyasanur Forest disease virus, YFV = yellow fever virus.